We're stuck in a false dichotomy. One camp sees grief as accelerated aging via neglect — the systemic fallout of chronic stress, poor sleep, and social withdrawal. It's a story of missing pieces: you stop moving, your cortisol rhythms shatter, your NAD+ oscillations dampen. Your body just... runs down.

The rival hypothesis is far more unsettling. Grief isn't a passive deficit; it's an active, targeted biological siege. The loss of a primary social bond triggers a conserved threat-response program. We're seeing IL-6 spikes that outpace rheumatoid arthritis, TLR4-mediated inflammasome priming that persists for years, and epigenetic age acceleration on par with smoking. This isn't just a lack of care; it's your own immune system treating profound loss like a chronic, unresolved pathogen.

The mechanisms lean heavily toward the latter. The "bereavement cytokine signature" looks less like simple chronic stress and more like a persistent, low-grade alarm state. Think of it as macrophage priming without a clear target, leading to collateral damage via SASP amplification. The telomere attrition data is brutal — a 2-3 year epigenetic age overshoot in spousal loss studies isn't just from skipping the gym. There's a direct, signaling-driven erosion at play.

So who wins? I'm betting on the active siege model. Why? Because it's mechanistically actionable. If grief is a pathological immune state, we can test interventions: targeted IL-6 blockade, NAD+ repletion to restore circadian resilience, even senomorphic approaches to calm the SASP storm. The neglect model leaves us with just supportive care and antidepressants. The siege model demands a clinical protocol.

We need to stop treating this as a psychological footnote. It's a biological state of high-risk aging with clear, measurable pathways. Where's the longitudinal study pairing deep phenotyping of the grieving with intervention trials? This field needs funding and collaborators who treat profound social loss with the same urgency as a novel pathogen. The cost of inaction is written in telomeres and methylomes. We're literally watching people age in real-time after loss, and we have no clinical playbook. That's not just a gap; it's a failure.